Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Neuromuscul Disord ; 27(12): 1106-1114, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29054426

RESUMEN

Myotonic dystrophy type 1 is caused by expansion of a CTG trinucleotide repeat situated in the DMPK gene. Worldwide genetic studies suggest a single or limited number of mutational events cause the disease. However, distribution of CTG alleles and disease incidence varies among ethnicities. Due to the great ethnic diversity of the Mexican population, the present study was aimed at analyzing the impact of different lineages in shaping the CTG-repeat allelic distribution in the contemporary Mexican-Mestizo population as well as to shed light on the DM1 ancestral origin. Distribution of CTG-repeat alleles was similar among Mestizo and Amerindian subpopulations with (CTG)11-13 being the most frequent alleles in both groups, which implies that Mexican-Mestizo allelic distribution has been modeled by Amerindian ancestry. We diagnosed a relatively high number of cases, consistent with the high frequency of large-normal alleles found in Mexican subpopulations. Haplotype analysis using various polymorphic-markers in proximity to DMPK gene indicates that a single founder mutation originates myotonic dystrophy type 1 in Mexico; however, Y-STR haplogroups data and the presence of pre-mutated and large normal alleles in Amerindians support the hypothesis that both European and Amerindian ancestral chromosomes might have introduced the disease to the Mexican population, which was further disseminated through mestizaje.


Asunto(s)
Frecuencia de los Genes/genética , Indígenas Norteamericanos/genética , Distrofia Miotónica/etnología , Distrofia Miotónica/genética , Proteína Quinasa de Distrofia Miotónica/genética , Expansión de Repetición de Trinucleótido/genética , Población Blanca/genética , Efecto Fundador , Humanos , México/etnología
2.
Acta Trop ; 42(2): 137-41, 1985 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-2862775

RESUMEN

A chemically defined medium to grow the promastigotes of 19 stocks of Leishmania is described. The medium was developed by making qualitative and quantitative modifications of the medium AR-103 devised for Trypanosoma cruzi. The new medium, designated as MD-29, can be used in studies on the nutritional requirements of promastigotes.


Asunto(s)
Medios de Cultivo , Leishmania/crecimiento & desarrollo , Parasitología/métodos , Animales , Medios de Cultivo/análisis , Leishmania/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA